Admission Date:  [**2123-9-20**]              Discharge Date:   [**2123-9-27**]  Date of Birth:  [**2079-11-21**]             Sex:   M  Service: MEDICINE  Allergies: Penicillins / morphine / cefepime  Attending:[**First Name3 (LF) 7591**] Chief Complaint: admit for scheduled chemothearpy  Major Surgical or Invasive Procedure: none   History of Present Illness: 43yo gentleman with AML here for scheduled admission for cycle 3 HiDAC.
Patient has AML-M5a diagnosed [**2123-4-25**] when he presented with septic arthritis of the right knee and dental infections.
He was found to have clonal loss of Y (usually considered a favorable cytogenetic finding) and no other cytogenitic abnormalities (NPM neg, FLT3 Neg) and was treated with 7+3 daunorubicin (90mg/m2) and cytarabine (100mg/m2/d x 7dCI) on [**5-14**].
Day 30 marrow was negative for disease and he was started on consolidation with HiDAC on [**2123-6-25**].
This was complicated by a morbilliform rash and there was some thought that this was due to cytarabine and the dose was reduced on days 3 and 5 to 2 g/m2.
Cycle 2 of High DAC was at full dose (3gm/m2 Q12 day 1,3,5 ) he had a minor rash but otherwise tolerated it well with a brief admission during his nadir for neutropenic malaise and chills at home (no temperature recorded).
He was treated with broad spectrum antibiotics until his counts recovered and he was discharged home.
ROS: per HPI, denies headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, BRBPR, melena, hematochezia, dysuria, hematuria.
Past Medical History: AML s/p induction with Ara-c/[**Doctor First Name **] and C2 of HiDAC GERD Right meniscal tear, s/p right knee arthroscopy, meniscectomy, and synovectomy [**2123-5-7**] Recent jaw infection ([**11/2122**])  Social History: Lives at home with wife and daughter.
TECHNIQUE:  Multiple axial slices were obtained within the abdomen and pelvis after administration of intravenous contrast and ingestion of oral contrast.
Spleen, pancreas and bilateral adrenals are normal in appearance.
PELVIS:  The urinary bladder contains a Foley catheter and is collapsed.
Brief Hospital Course: 43M with AML-M5a admitted for scheduled cycle 3 HiDAC consolidation chemotherapy who was transferred to the [**Hospital Unit Name 153**] of Day2 for hypotension, fever tachycardia,  # Acute myelogenous leukemia (monocytic): AML-M5a diagnosed [**2123-4-25**] when he presented with septic arthritis of the right knee and dental infections.
Had 7+3 dauno and cytarabine induction, and initiated cycle 3 HiDAC this admission with the following.
The patient will follow up with outpatient oncologist Dr. [**Last Name (STitle) 410**] to discuss further chemotherapy course.
WBC was 13.2 and lactate 3.1  He received agressive fluid resuscitation.
His PICC was removed given concern for possible line infection, the tip was sent for culture, and was ultimately negative.
He was started on Vancomycin, and Meropenem, remained afebrile, hemodynamically stable, and transferred back to the floor on  [**2123-9-23**].
His Vancomycin was discontinued on [**9-25**] and Meropenem was discontinued on [**9-26**].
The patient was transitoned to PO ciprofloxacin and flagyl for treatment of typhilitis for which he will complete a 5 day course.
During the work up of his hypotension in the [**Hospital Unit Name 153**] the patient was evaluted for adrenal insufficency.
He had a cortisol stimulation test on [**9-23**] with a borderline suboptimal response, and low baseline cortisol, and was started on stress dose steroids.
On transfer to the floor the patient was formally evaluated by endocrine, who recommended a repeat cortisol stimulation test, since the  patient had received dexamethasone prior to the first test.
His stress dose steroid were also discontinued and a repeat cortisol stimulation test was done 24hours after the patient's last stress dose steroids.
Of note the patient did not receive dexamethasone prior to this dose.
The patient used topical triamcinolone cream and diphehydramine PRN and the rash ultimately resolved prior to discharge  ----------- CHRONIC STABLE ISSUES  #Anal fissure: Improved per patient, no signs of fissure or peri-rectal abscess on exam.
Continued home oxycodone as needed.
Medications on Admission: Preadmission medications listed are correct and complete.
Docusate Sodium 100 mg PO TID 2.
Lorazepam 0.5 mg PO Q6H:PRN nausea 3.
Ondansetron 8 mg PO Q8H:PRN nausea 4.
OxycoDONE (Immediate Release)  5-10 mg PO Q4H:PRN pain 5.
Pantoprazole 40 mg PO Q12H 6.
Senna 2 TAB PO BID 7.
DimenhyDRINATE 50 mg PO Q6H:PRN nausea 8. lidocaine-hyalur ac-aloe-[**Last Name (un) **] *NF* 2 %-4  Topical TID:PRN mouth pain 9.
Oxycodone SR (OxyconTIN) 10 mg PO HS 10.
Potassium Chloride 20 mEq PO BID 11.
Prochlorperazine 10 mg PO Q6H:PRN nausea 12.
Lidocaine 5% Ointment 1 Appl TP PRN bowel movement apply small amount externally to affected area prior to bowel movement 13.
Acyclovir 400 mg PO Q8H 14.
Polyethylene Glycol 17 g PO DAILY:PRN constipation   Discharge Medications: 1.
Acyclovir 400 mg PO Q8H 2.
Docusate Sodium 100 mg PO TID 3.
Lorazepam 0.5 mg PO Q6H:PRN nausea 4.
Ondansetron 8 mg PO Q8H:PRN nausea 5.
OxycoDONE (Immediate Release)  5-10 mg PO Q4H:PRN pain 6.
Oxycodone SR (OxyconTIN) 10 mg PO HS 7.
Pantoprazole 40 mg PO Q12H 8.
Polyethylene Glycol 17 g PO DAILY:PRN constipation 9.
Potassium Chloride 20 mEq PO BID 10.
Senna 2 TAB PO BID 11.
DimenhyDRINATE 50 mg PO Q6H:PRN nausea 12.
Lidocaine 5% Ointment 1 Appl TP PRN bowel movement apply small amount externally to affected area prior to bowel movement 13. lidocaine-hyalur ac-aloe-[**Last Name (un) **] *NF* 2 %-4  Topical TID:PRN mouth pain 14.
Prochlorperazine 10 mg PO Q6H:PRN nausea 15.
Ciprofloxacin HCl 500 mg PO Q12H total course of 5 days (last day [**10-1**]) RX *ciprofloxacin [Cipro] 500 mg 1 tablet(s) by mouth 12h Disp #*8 Tablet Refills:*0 16.
MetRONIDAZOLE (FLagyl) 500 mg PO Q8H total course of 5 days (last day [**10-1**]) RX *metronidazole [Flagyl] 500 mg 1 tablet(s) by mouth 8H Disp #*12 Tablet Refills:*0   Discharge Disposition: Home  Discharge Diagnosis: Primary: acute myelogenous leukemia  Secondary: gastroesophageal reflux disease chronic knee pain   Discharge Condition: Mental Status: Clear and coherent.
Activity Status: Ambulatory   Discharge Instructions: Dear Mr. [**Known lastname 284**],  It was a pleasure taking part in your care during your hospitalization at [**Hospital1 18**].
You were admitted for scheduled chemotherapy for your acute myelogenous leukemia.
You were transferred to the ICU, started on antibiotics, and given a lot of IV fluids to help increase your blood pressure.
